SCHLUMBERGER LIMITEDNV
For the period ended Mar 31, 2025. Filed Apr 25, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 25, 2025
Contents
Item 1. Financial Statements
CONSOLIDATED STATEMENT OF INCOME
| (Stated in millions, except per share amounts) | ||
|---|---|---|
| Three Months Ended March 31, | ||
| 2025 | 2024 | |
| Revenue | ||
| Services | $5,366 | $5,676 |
| Product sales | 3,124 | 3,031 |
| Total Revenue | 8,490 | 8,707 |
| Interest & other income | 78 | 84 |
| Expenses | ||
| Cost of services | 4,256 | 4,415 |
| Cost of sales | 2,628 | 2,592 |
| Research & engineering | 172 | 182 |
| General & administrative | 96 | 121 |
| Restructuring | 158 | - |
| Merger & integration | 48 | 11 |
| Interest | 147 | 113 |
| Income before taxes | 1,063 | 1,357 |
| Tax expense | 234 | 259 |
| Net income | 829 | 1,098 |
| Net income attributable to noncontrolling interests | 32 | 30 |
| Net income attributable to SLB | $797 | $1,068 |
| Basic income per share of SLB | $0.58 | $0.75 |
| Diluted income per share of SLB | $0.58 | $0.74 |
| Average shares outstanding: | ||
| Basic | 1,366 | 1,431 |
| Assuming dilution | 1,380 | 1,447 |
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
| (Stated in millions) | ||
|---|---|---|
| Three Months Ended March 31, | ||
| 2025 | 2024 | |
| Net income | $829 | $1,098 |
| Currency translation adjustments | ||
| Unrealized net change arising during the period | 172 | 23 |
| Cash flow hedges | ||
| Net loss on cash flow hedges | (65) | (17) |
| Reclassification to net income of net realized loss (gain) | 5 | (1) |
| Pension and other postretirement benefit plans | ||
| Amortization to net income of net actuarial gain | 8 | - |
| Amortization to net income of net prior service credit | (3) | (6) |
| Income taxes on pension and other postretirement benefit plans | - | 1 |
| Other | 9 | 5 |
| Comprehensive income | 955 | 1,103 |
| Comprehensive income attributable to noncontrolling interests | 32 | 30 |
| Comprehensive income attributable to SLB | $923 | $1,073 |
CONSOLIDATED BALANCE SHEET
| (Stated in millions) | ||
|---|---|---|
| Mar. 31, | ||
| 2025 | Dec. 31, | |
| (Unaudited) | 2024 | |
| ASSETS | ||
| Current Assets | ||
| Cash | $2,936 | $3,544 |
| Short-term investments | 961 | 1,125 |
| Receivables less allowance for doubtful accounts (2025 - $339; 2024 - $325) | 8,604 | 8,011 |
| Inventories | 4,650 | 4,375 |
| Other current assets | 1,444 | 1,515 |
| 18,595 | 18,570 | |
| Investments in Affiliated Companies | 1,641 | 1,635 |
| Fixed Assets less accumulated depreciation | 7,399 | 7,359 |
| Goodwill | 14,637 | 14,593 |
| Intangible Assets | 2,963 | 3,012 |
| Other Assets | 3,767 | 3,766 |
| $49,002 | $48,935 | |
| LIABILITIES AND EQUITY | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | $10,221 | $10,375 |
| Estimated liability for taxes on income | 936 | 982 |
| Short-term borrowings and current portion of long-term debt | 3,475 | 1,051 |
| Dividends payable | 404 | 403 |
| 15,036 | 12,811 | |
| Long-term Debt | 10,527 | 11,023 |
| Postretirement Benefits | 507 | 512 |
| Deferred Taxes | 37 | 67 |
| Other Liabilities | 2,147 | 2,172 |
| 28,254 | 26,585 | |
| Equity | ||
| Common stock | 10,827 | 11,458 |
| Treasury stock | (3,292) | (1,773) |
| Retained earnings | 16,804 | 16,395 |
| Accumulated other comprehensive loss | (4,824) | (4,950) |
| SLB stockholders’ equity | 19,515 | 21,130 |
| Noncontrolling interests | 1,233 | 1,220 |
| 20,748 | 22,350 | |
| $49,002 | $48,935 | |
CONSOLIDATED STATEMENT OF CASH FLOWS
| (Stated in millions) | ||
|---|---|---|
| Three Months Ended March 31, | ||
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net income | $829 | $1,098 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization (1) | 640 | 600 |
| Deferred taxes | (37) | (30) |
| Stock-based compensation expense | 91 | 100 |
| Earnings of equity method investments, less dividends received | (10) | (16) |
| Change in assets and liabilities: (2) | ||
| Increase in receivables | (472) | (429) |
| Increase in inventories | (214) | (172) |
| Decrease in other current assets | 80 | 46 |
| (Increase) decrease in other assets | (11) | 7 |
| Decrease in accounts payable and accrued liabilities | (275) | (874) |
| Decrease in estimated liability for taxes on income | (56) | (46) |
| Increase in other liabilities | 27 | 5 |
| Other | 68 | 38 |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 660 | 327 |
| Cash flows from investing activities: | ||
| Capital expenditures | (398) | (399) |
| APS investments | (108) | (121) |
| Exploration data costs capitalized | (51) | (29) |
| Business acquisitions and investments, net of cash acquired | (37) | (27) |
| Sales of short-term investments, net | 177 | 390 |
| Purchase of Blue Chip Swap securities | (75) | (52) |
| Proceeds from sale of Blue Chip securities | 63 | 34 |
| Other | (3) | 53 |
| NET CASH USED IN INVESTING ACTIVITIES | (432) | (151) |
| Cash flows from financing activities: | ||
| Dividends paid | (386) | (357) |
| Proceeds from employee stock purchase plan | 105 | 100 |
| Proceeds from exercise of stock options | 8 | 15 |
| Taxes paid on net settled stock-based compensation awards | (53) | (78) |
| Stock repurchase program | (2,300) | (270) |
| Proceeds from issuance of long-term debt | 1,805 | 345 |
| Repayment of long-term debt | - | - |
| Net decrease in short-term borrowings | (27) | (9) |
| Other | (30) | (13) |
| NET CASH USED IN FINANCING ACTIVITIES | (878) | (267) |
| Net decrease in cash before translation effect | (650) | (91) |
| Translation effect on cash | 42 | (21) |
| Cash, beginning of period | 3,544 | 2,900 |
| Cash, end of period | $2,936 | $2,788 |
(1)
Includes depreciation of fixed assets and amortization of intangible assets, exploration data costs, and Asset Performance Solutions ("APS") investments.
(2)
Net of the effect of business acquisitions.
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
| (Stated in millions, except per share amounts) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated | |||||||||||||
| Other | |||||||||||||
| Common Stock · Retained · Comprehensive · Noncontrolling | |||||||||||||
| January 1, 2025 – March 31, 2025 · Issued · In Treasury · Earnings · Loss · Interests · Total | |||||||||||||
| Balance, January 1, 2025 | $11,458 | $(1,773) | $16,395 | $(4,950) | $1,220 | $22,350 | |||||||
| Net income | 797 | 32 | 829 | ||||||||||
| Currency translation adjustments | 172 | 172 | |||||||||||
| Changes in fair value of cash flow hedges | (60) | (60) | |||||||||||
| Pension and other postretirement benefit plans | 5 | 5 | |||||||||||
| Shares sold to optionees, less shares exchanged | (1) | 9 | 8 | ||||||||||
| Vesting of restricted stock, net of taxes withheld | (217) | 164 | (53) | ||||||||||
| Employee stock purchase plan | (44) | 149 | 105 | ||||||||||
| Stock repurchase program | (1,840) | (1,840) | |||||||||||
| Advance payment for accelerated share repurchases | (460) | (460) | |||||||||||
| Stock-based compensation expense | 91 | 91 | |||||||||||
| Dividends declared ($0.285 per share) | (388) | (388) | |||||||||||
| Other | (1) | 9 | (19) | (11) | |||||||||
| Balance, March 31, 2025 | $10,827 | $(3,292) | $16,804 | $(4,824) | $1,233 | $20,748 | |||||||
| Accumulated | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Other | |||||||||||
| Common Stock · Retained · Comprehensive · Noncontrolling | |||||||||||
| January 1, 2024 – March 31, 2024 · Issued · In Treasury · Earnings · Loss · Interests · Total | |||||||||||
| Balance, January 1, 2024 | $11,624 | $(678) | $13,497 | $(4,254) | $1,170 | $21,359 | |||||
| Net income | 1,068 | 30 | 1,098 | ||||||||
| Currency translation adjustments | 23 | 23 | |||||||||
| Changes in fair value of cash flow hedges | (18) | (18) | |||||||||
| Pension and other postretirement benefit plans | (5) | (5) | |||||||||
| Shares sold to optionees, less shares exchanged | (6) | 21 | 15 | ||||||||
| Vesting of restricted stock, net of taxes withheld | (338) | 260 | (78) | ||||||||
| Employee stock purchase plan | (36) | 136 | 100 | ||||||||
| Stock repurchase program | (270) | (270) | |||||||||
| Stock-based compensation expense | 100 | 100 | |||||||||
| Dividends declared ($0.275 per share) | (393) | (393) | |||||||||
| Other | 5 | (13) | (8) | ||||||||
| Balance, March 31, 2024 | $11,344 | $(531) | $14,172 | $(4,249) | $1,187 | $21,923 | |||||
SHARES OF COMMON STOCK
| (Stated in millions) | |||
|---|---|---|---|
| Shares | |||
| Issued | In Treasury | Outstanding | |
| Balance, January 1, 2025 | 1,439 | (38) | 1,401 |
| Vesting of restricted stock | - | 4 | 4 |
| Shares issued under employee stock purchase plan | - | 3 | 3 |
| Stock repurchase program | - | (48) | (48) |
| Balance, March 31, 2025 | 1,439 | (79) | 1,360 |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- Basis of Presentation
The accompanying unaudited consolidated financial statements of Schlumberger Limited and its subsidiaries (“SLB”) have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of SLB management, all adjustments considered necessary for a fair statement have been included in the accompanying unaudited financial statements. All intercompany transactions and balances have been eliminated in consolidation. Operating results for the three-month period ended March 31, 2025 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2025. The December 31, 2024 balance sheet information has been derived from the SLB 2024 audited financial statements. For further information, refer to the Consolidated Financial Statements and notes thereto included in the SLB Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission on January 22, 2025.
ChampionX Transaction
On April 2, 2024, SLB announced a definitive agreement to purchase ChampionX Corporation ("ChampionX") in an all-stock transaction. ChampionX is a global leader in chemistry solutions, artificial lift systems, and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently, and sustainably around the world. Under the terms of the agreement, ChampionX shareholders will receive 0.735 shares of SLB common stock in exchange for each ChampionX share. At the closing of the transaction ChampionX shareholders will own approximately 9% of SLB's outstanding shares of common stock. ChampionX reported revenue of approximately $3.6 billion in 2024. The transaction, which is subject to regulatory approvals and other customary closing conditions, received the approval of the ChampionX stockholders at a special meeting held on June 18, 2024. It is anticipated that the transaction will close in the second quarter or early third quarter of 2025.
- Charges and Credits
During the second quarter of 2024, SLB started a program to realign and optimize its support and service delivery structure in certain parts of its organization. As a result, SLB recorded severance charges of $158 million during the first quarter of 2025. These costs are classified in Restructuringin the Consolidated Statement of Income. SLB may record additional charges related to workforce reductions in 2025 as it aligns its resources with activity levels.
During the first quarter of 2025, in connection with the pending ChampionX transaction and the October 2023 acquisition of the Aker Solutions subsea business, SLB recorded $48 million of charges related to merger and integration-related costs. These costs are classified in Merger & integration in the Consolidated Statement of Income.
| (Stated in millions) | |||||
|---|---|---|---|---|---|
| Noncontrolling | |||||
| Pretax Charge · Tax Benefit · Interests · Net | |||||
| Workforce reductions | $158 | $10 | $ | - | $148 |
| Merger and integration-related | 48 | 1 | 4 | 43 | |
| $206 | $11 | $4 | $191 | ||
In connection with SLB's October 2023 acquisition of the Aker Solutions subsea business, SLB recorded $25 million of pretax charges during the first quarter of 2024 consisting of: $14 million relating to the amortization of purchase accounting adjustments associated with the write-up of acquired inventories to its estimated fair value and $11 million of other merger and integration-related costs. $14 million of these costs are classified in Cost of sales in the Consolidated Statement of Income, with the remaining $11 million classified in Merger & integration.
| (Stated in millions) | ||||
|---|---|---|---|---|
| Noncontrolling | ||||
| Pretax Charge | Tax Benefit | Interests | Net | |
| Merger and integration-related | $25 | $6 | $5 | $14 |
- Earnings per Share
The following is a reconciliation from basic earnings per share of SLB to diluted earnings per share of SLB:
| (Stated in millions, except per share amounts) | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2025 · 2024 | ||||||||
| Net IncomeAttributableto SLB · Average SharesOutstanding · Earnings perShare · Net IncomeAttributableto SLB · Average SharesOutstanding · Earnings perShare | ||||||||
| First Quarter | ||||||||
| Basic | $797 | 1,366 | $0.58 | $1,068 | 1,431 | $0.75 | ||
| Assumed exercise of stock options | - | - | - | 1 | ||||
| Unvested restricted stock | - | 14 | - | 15 | ||||
| Diluted | $797 | 1,380 | $0.58 | $1,068 | 1,447 | $0.74 | ||
The number of outstanding options to purchase shares of SLB common stock that were not included in the computation of diluted income per share, because to do so would have had an antidilutive effect, was as follows:
| (Stated in millions) | ||
|---|---|---|
| Three Months Ended March 31, | ||
| 2025 | 2024 | |
| Employee stock options | 17 | 20 |
- Inventories
A summary of inventories, which are stated at the lower of average cost or net realizable value, is as follows:
| (Stated in millions) | ||
|---|---|---|
| Mar, 31, | Dec. 31, | |
| 2025 | 2024 | |
| Raw materials & field materials | $2,566 | $2,387 |
| Work in progress | 835 | 786 |
| Finished goods | 1,249 | 1,202 |
| $4,650 | $4,375 | |
- Fixed Assets
Fixed assets consist of the following:
| (Stated in millions) | ||
|---|---|---|
| Mar. 31, | Dec. 31, | |
| 2025 | 2024 | |
| Property, plant & equipment | $30,039 | $29,573 |
| Less: Accumulated depreciation | 22,640 | 22,214 |
| $7,399 | $7,359 | |
Depreciation expense relating to fixed assets was $397 million and $377 million in the first quarter of 2025 and 2024, respectively.
- Intangible Assets
Intangible assets consist of the following:
| (Stated in millions) | ||||||
|---|---|---|---|---|---|---|
| Mar. 31, 2025 | Dec. 31, 2024 | |||||
| Gross | Accumulated | Net Book | Gross | Accumulated | Net Book | |
| Book Value | Amortization | Value | Book Value | Amortization | Value | |
| Customer relationships | $1,887 | $822 | $1,065 | $1,887 | $799 | $1,088 |
| Technology/technical know-how | 1,614 | 897 | 717 | 1,588 | 872 | 716 |
| Tradenames | 795 | 308 | 487 | 795 | 299 | 496 |
| Other | 1,612 | 918 | 694 | 1,604 | 892 | 712 |
| $5,908 | $2,945 | $2,963 | $5,874 | $2,862 | $3,012 | |
Amortization expense charged to income was $82 million during the first quarter of 2025 and $81 million during the first quarter of 2024.
Based on the carrying value of intangible assets at March 31, 2025, amortization expense for the subsequent five years is estimated to be: remaining three quarters 2025—$242 million; 2026—$315 million; 2027—$311 million; 2028—$301 million; 2029—$288 million; and 2030—$283 million.
- Long-term Debt
Long-term Debt consists of the following:
| (Stated in millions) | ||
|---|---|---|
| Mar. 31, | Dec. 31, | |
| 2025 | 2024 | |
| 3.90% Senior Notes due 2028 | $1,480 | $1,478 |
| 2.65% Senior Notes due 2030 | 1,246 | 1,250 |
| 1.375% Guaranteed Notes due 2026 | 1,076 | 1,040 |
| 2.00% Guaranteed Notes due 2032 | 1,070 | 1,034 |
| 0.25% Notes due 2027 | 969 | 936 |
| 0.50% Notes due 2031 | 967 | 935 |
| 4.30% Senior Notes due 2029 | 848 | 848 |
| 4.50% Senior Notes due 2028 | 496 | 497 |
| 5.00% Senior Notes due 2027 | 496 | 495 |
| 4.85% Senior Notes due 2033 | 494 | 498 |
| 5.00% Senior Notes due 2029 | 493 | 493 |
| 5.00% Senior Notes due 2034 | 486 | 489 |
| 7.00% Notes due 2038 | 197 | 197 |
| 5.95% Notes due 2041 | 111 | 111 |
| 5.13% Notes due 2043 | 98 | 98 |
| 1.00% Guaranteed Notes due 2026 | - | 624 |
| $10,527 | $11,023 | |
The estimated fair value of SLB’s Long-term Debt, based on quoted market prices at March 31, 2025 and December 31, 2024, was $10.0 billion and $10.4 billion, respectively.
At March 31, 2025, SLB had committed credit facility agreements with commercial banks aggregating $5.0 billion, of which $2.0 billion matures in February 2028 and$3.0 billion matures in December 2029. These committed facilities support commercial paper programs in the United States and Europe. There wereno borrowings under these facilities at March 31, 2025 and December 31, 2024,
Commercial paper borrowings are classified as long-term debt to the extent they are backed up by available and unused committed credit facilities maturing in more than one year and to the extent it is SLB’s intent to maintain these obligations for longer than one year. Borrowings under the commercial paper programs at March 31, 2025, were $1.8 billion, all of which were classified in Short-term borrowings and current portion of long-term debt in the Consolidated Balance Sheet. There wereno borrowings under the commercial paper programs at December 31, 2024.
Schlumberger Limited fully and unconditionally guarantees the securities issued by certain of its subsidiaries, including securities issued by Schlumberger Investment S.A. and Schlumberger Finance Canada Ltd., both indirect wholly-owned subsidiaries of Schlumberger Limited.
- Derivative Instruments and Hedging Activities
SLB’s functional currency is primarily the US dollar. However, outside the United States, a significant portion of SLB’s expenses is incurred in foreign currencies. Therefore, when the US dollar weakens (strengthens) in relation to the foreign currencies of the countries in which SLB conducts business, the US dollar-reported expenses will increase (decrease).
Changes in foreign currency exchange rates expose SLB to risks on future cash flows relating to its fixed rate debt denominated in currencies other than the functional currency. SLB uses cross-currency interest rate swaps to provide a hedge against these risks. These contracts are accounted for as cash flow hedges, with the fair value of the derivative recorded on the Consolidated Balance Sheetand in Accumulated other comprehensive loss. Amounts recorded in Accumulated other comprehensive lossare reclassified into earnings in the same period or periods that the hedged item is recognized in earnings.
Details regarding SLB’s outstanding cross-currency interest rate swaps as of March 31, 2025, were as follows:
During 2019, SLB entered into cross-currency interest rate swaps in order to hedge changes in the fair value of its €0.5 billion 0.25% Notes due 2027 and €0.5 billion 0.50% Notes due 2031 that were issued by a US-dollar functional currency subsidiary. These cross-currency interest rate swaps effectively convert the Euro-denominated notes to US-dollar denominated debt with fixed annual interest rates of 2.51% and 2.76%, respectively.
During 2020, a US-dollar functional currency subsidiary of SLB issued €0.8 billion of Euro-denominated debt. SLB entered into cross-currency interest rate swaps to hedge changes in the US dollar value of its €0.4 billion of 0.25% Notes due 2027 and €0.4 billion of 0.50% Notes due 2031. These cross-currency interest rate swaps effectively convert the Euro-denominated notes to US-dollar denominated debt with fixed annual interest rates of 1.87% and 2.20%, respectively.
During 2020, a US-dollar functional currency subsidiary of SLB issued €2.0 billion of Euro-denominated debt. SLB entered into cross-currency interest rate swaps to hedge changes in the US dollar value of its €1.0 billion of 1.375% Guaranteed Notes due 2026 and €1.0 billion of 2.00% Guaranteed Notes due 2032. These cross-currency interest rate swaps effectively convert the Euro-denominated notes to US-dollar denominated debt with fixed annual interest rates of 2.77% and 3.49%, respectively.
During 2020, a Canadian dollar functional currency subsidiary of SLB issued $0.5 billion of US dollar denominated debt. SLB entered into cross-currency interest rate swaps to hedge changes in the US dollar value of its $0.5 billion 1.40% Senior Notes due 2025. These cross-currency interest rate swaps effectively convert the US dollar notes to Canadian dollar denominated debt with a fixed annual interest rate of 1.73%.
A summary of the amounts included in the Consolidated Balance Sheet relating to cross currency interest rate swaps was as follows:
| (Stated in millions) | ||
|---|---|---|
| Mar. 31, 2025 | Dec. 31, 2024 | |
| Other current assets | $38 | $37 |
| Other Assets | $3 | $2 |
| Other Liabilities | $136 | $183 |
The fair values were determined using a model with inputs that are observable in the market or can be derived or corroborated by observable data.
SLB is exposed to risks on future cash flows to the extent that the local currency is not the functional currency and expenses denominated in local currency are not equal to revenues denominated in local currency. SLB uses foreign currency forward contracts to provide a hedge against a portion of these cash flow risks. These contracts are accounted for as cash flow hedges.
SLB is also exposed to changes in the fair value of assets and liabilities denominated in currencies other than the functional currency. While SLB uses foreign currency forward contracts to economically hedge this exposure as it relates to certain currencies, these contracts are not designated as hedges for accounting purposes. Instead, the fair value of the derivative is recorded on the Consolidated Balance Sheetand changes in the fair value are recognized in the Consolidated Statement of Income, as are changes in the fair value of the hedged item.
Foreign currency forward contracts were outstanding for the US dollar equivalent of $5.0 billion and $5.5 billion in various foreign currencies as of March 31, 2025 and December 31, 2024, respectively.
Other than the previously mentioned cross-currency interest rate swaps, the fair value of the other outstanding derivativeswasnot materialas of March 31, 2025 and December 31, 2024.
The effect of derivative instruments designated as cash flow hedges, and those not designated as hedges, on the Consolidated Statement of Incomewas as follows:
| (Stated in millions) | |||
|---|---|---|---|
| Gain (Loss) Recognized in Income | |||
| First Quarter | |||
| 2025 | 2024 | Consolidated Statement of Income Classification | |
| Derivatives designated as cash flow hedges: | |||
| Cross-currency interest rate swaps | $136 | $(94) | Cost of services/sales |
| Cross-currency interest rate swaps | (19) | (21) | Interest expense |
| Commodity contracts | - | (3) | Revenue |
| Foreign currency forward contracts | (1) | - | Cost of services/sales |
| Foreign currency forward contracts | (4) | 3 | Revenue |
| $112 | $(115) | ||
| Derivatives not designated as hedges: | |||
| Foreign currency forward contracts | $25 | $5 | Cost of services/sales |
SLB has issued credit default swaps (“CDSs”) to certain third-party financial institutions that have an aggregate notional amount outstanding of approximately $1.2 billion as of March 31, 2025. The CDSs relate to borrowings provided by the financial institutions to SLB’s primary customer in Mexico. The borrowings were used by this customer to pay certain of SLB’s outstanding receivables. Approximately $0.3 billion of the outstanding CDSs reduces on a monthly basis over its remaining 11-month term while the remaining $0.9 billion reduces on a monthly basis over its remaining 15-month term. The fair value of these derivative liabilities was not material at March 31, 2025.
- Contingencies
SLB is party to various legal proceedings from time to time. A liability is accrued when a loss is both probable and can be reasonably estimated. Management believes that the probability of a material loss with respect to any currently pending legal proceeding is remote. However, litigation is inherently uncertain, and it is not possible to predict the ultimate disposition of any of these proceedings.
- Segment Information
| (Stated in millions) | ||||||
|---|---|---|---|---|---|---|
| First Quarter 2025 · First Quarter 2024 | ||||||
| Income · Income | ||||||
| Revenue · Before Taxes · Revenue · Before Taxes | ||||||
| Digital & Integration | $1,006 | $306 | $953 | $254 | ||
| Reservoir Performance | 1,700 | 282 | 1,725 | 339 | ||
| Well Construction | 2,977 | 589 | 3,368 | 690 | ||
| Production Systems | 2,938 | 475 | 2,818 | 400 | ||
| Eliminations & other | (131) | (96) | (157) | (34) | ||
| 1,556 | 1,649 | |||||
| Corporate & other (1) | (179) | (191) | ||||
| Interest income (2) | 36 | 34 | ||||
| Interest expense (3) | (144) | (110) | ||||
| Charges and credits (4) | (206) | (25) | ||||
| $8,490 | $1,063 | $8,707 | $1,357 | |||
(1)
Comprised principally of certain corporate expenses not allocated to the segments, stock-based compensation costs, amortization expense associated with certain intangible assets, certain centrally managed initiatives and other nonoperating items.
(2)
Interest income excludes amounts that are included in the segments’ income ($- million in 2025; $4 million in 2024).
(3)
Interest expense excludes amounts that are included in the segments’ income ($3 million in 2025; $3 million in 2024).
(4)
See Note 2 –Charges and Credits.
Revenue by geographic area was as follows:
| (Stated in millions) | ||
|---|---|---|
| First Quarter | ||
| 2025 | 2024 | |
| North America | $1,719 | $1,598 |
| Latin America | 1,495 | 1,654 |
| Europe & Africa (1) | 2,235 | 2,322 |
| Middle East & Asia | 2,997 | 3,080 |
| Other | 44 | 53 |
| $8,490 | $8,707 | |
(1)
Includes Russia and the Caspian region.
North America and International revenue disaggregated by segment was as follows:
| (Stated in millions) | |||||
|---|---|---|---|---|---|
| North | |||||
| America · International · Other · Total | |||||
| Digital & Integration | $289 | $717 | $ | - | $1,006 |
| Reservoir Performance | 142 | 1,557 | 1 | 1,700 | |
| Well Construction | 541 | 2,381 | 55 | 2,977 | |
| Production Systems | 768 | 2,166 | 4 | 2,938 | |
| Eliminations & other | (21) | (94) | (16) | (131) | |
| $1,719 | $6,727 | $44 | $8,490 | ||
| North | |||||
| America · International · Other · Total | |||||
| Digital & Integration | $236 | $717 | $ | - | $953 |
| Reservoir Performance | 130 | 1,592 | 3 | 1,725 | |
| Well Construction | 604 | 2,707 | 57 | 3,368 | |
| Production Systems | 647 | 2,164 | 7 | 2,818 | |
| Eliminations & other | (19) | (124) | (14) | (157) | |
| $1,598 | $7,056 | $53 | $8,707 | ||
Significant segment expenses, which represents the difference between segment revenue and pretax segment income, consist of the following:
| (Stated in millions) | ||||
|---|---|---|---|---|
| Digital & | Reservoir | Well | Production | |
| Integration | Performance | Construction | Systems | |
| Compensation | $206 | $407 | $604 | $241 |
| Cost of products, materials, and supplies | - | 309 | 802 | 1,820 |
| Depreciation and amortization | 166 | 104 | 164 | 90 |
| Allocations | 101 | 165 | 250 | 137 |
| Other | 227 | 433 | 568 | 175 |
| $700 | $1,418 | $2,388 | $2,463 | |
| Digital & | Reservoir | Well | Production | |
| Integration | Performance | Construction | Systems | |
| Compensation | $221 | $392 | $654 | $294 |
| Cost of products, materials, and supplies | - | 298 | 926 | 1,761 |
| Depreciation and amortization | 148 | 99 | 156 | 82 |
| Allocations | 107 | 162 | 251 | 129 |
| Other | 223 | 435 | 691 | 152 |
| $699 | $1,386 | $2,678 | $2,418 | |
Other segment expenses include transportation, mobilization, lease, occupancy, professional, and other costs.
Revenue in excess of billings related to contracts where revenue is recognized over time was$0.6 billion at March 31, 2025 and $0.5 billion at December 31, 2024. Such amounts are included within Receivables less allowance for doubtful accounts in the Consolidated Balance Sheet.
Total backlog was$5.6 billion at March 31, 2025, of which approximately 60%is expected to be recognized as revenue over the next 12 months.
Billings and cash collections in excess of revenue was $2.1 billion at March 31, 2025 and $2.0 billion at December 31, 2024. Such amounts are included within Accounts payable and accrued liabilities in the Consolidated Balance Sheet.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.